P098 National, transparent inclusion process provided maximal opportunities for Dutch people with CF to participate in clinical trial.

Autor: Paalvast, I.1 (AUTHOR), Eggermont, M.N.1 (AUTHOR), Geel, A.L.2 (AUTHOR), Michel, S.3 (AUTHOR), Keijzers, N.4 (AUTHOR), Adriaens, N.5 (AUTHOR), Zwitserloot, A.M.6 (AUTHOR), Bannier, M.A.G.E.7 (AUTHOR), Bakker, M.2 (AUTHOR), van der Meer, R.1 (AUTHOR), Zomer-van Ommen, D.8 (AUTHOR)
Zdroj: Journal of Cystic Fibrosis. 2024 Supplement 1, Vol. 23, pS97-S97. 1p.
Databáze: Academic Search Ultimate
Externí odkaz: